1. Home
  2. EBS vs BGR Comparison

EBS vs BGR Comparison

Compare EBS & BGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBS
  • BGR
  • Stock Information
  • Founded
  • EBS 1998
  • BGR 2004
  • Country
  • EBS United States
  • BGR United States
  • Employees
  • EBS N/A
  • BGR N/A
  • Industry
  • EBS Biotechnology: Pharmaceutical Preparations
  • BGR Trusts Except Educational Religious and Charitable
  • Sector
  • EBS Health Care
  • BGR Finance
  • Exchange
  • EBS Nasdaq
  • BGR Nasdaq
  • Market Cap
  • EBS 359.3M
  • BGR 350.6M
  • IPO Year
  • EBS 2006
  • BGR N/A
  • Fundamental
  • Price
  • EBS $8.15
  • BGR $13.62
  • Analyst Decision
  • EBS Strong Buy
  • BGR
  • Analyst Count
  • EBS 3
  • BGR 0
  • Target Price
  • EBS $14.33
  • BGR N/A
  • AVG Volume (30 Days)
  • EBS 1.0M
  • BGR 73.3K
  • Earning Date
  • EBS 11-05-2025
  • BGR 01-01-0001
  • Dividend Yield
  • EBS N/A
  • BGR 6.02%
  • EPS Growth
  • EBS N/A
  • BGR N/A
  • EPS
  • EBS 2.53
  • BGR 0.69
  • Revenue
  • EBS $851,600,000.00
  • BGR N/A
  • Revenue This Year
  • EBS N/A
  • BGR N/A
  • Revenue Next Year
  • EBS $19.24
  • BGR N/A
  • P/E Ratio
  • EBS $3.25
  • BGR $18.97
  • Revenue Growth
  • EBS N/A
  • BGR N/A
  • 52 Week Low
  • EBS $4.02
  • BGR $11.38
  • 52 Week High
  • EBS $12.73
  • BGR $13.37
  • Technical
  • Relative Strength Index (RSI)
  • EBS 51.40
  • BGR 57.53
  • Support Level
  • EBS $7.45
  • BGR $13.55
  • Resistance Level
  • EBS $8.62
  • BGR $13.69
  • Average True Range (ATR)
  • EBS 0.40
  • BGR 0.15
  • MACD
  • EBS -0.10
  • BGR 0.01
  • Stochastic Oscillator
  • EBS 38.46
  • BGR 79.73

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

About BGR BlackRock Energy and Resources Trust

BlackRock Energy & Resources Trust is a closed-end equity fund providing total return through a combination of current income, gains and capital appreciation by investing in equity securities and derivatives of energy and natural resources companies. The fund invests in various sectors such as information technology, financials, healthcare, consumer discretionary, industrial, energy, materials and utilities.

Share on Social Networks: